Sheron C. Lear

597 total citations
16 papers, 440 citations indexed

About

Sheron C. Lear is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Sheron C. Lear has authored 16 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Sheron C. Lear's work include Bone Metabolism and Diseases (3 papers), T-cell and Retrovirus Studies (2 papers) and Nail Diseases and Treatments (2 papers). Sheron C. Lear is often cited by papers focused on Bone Metabolism and Diseases (3 papers), T-cell and Retrovirus Studies (2 papers) and Nail Diseases and Treatments (2 papers). Sheron C. Lear collaborates with scholars based in United States, Australia and Egypt. Sheron C. Lear's co-authors include Alvin W. Martin, Anthony J. Janckila, Lung T. Yam, Stephen P. Slone, Janine C. Malone, Hadi Yaziji, L. Jane Goldsmith, Antoinette F. Hood, Paul Fearneyhough and Jeffrey P. Callen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Histochemistry & Cytochemistry and American Journal of Clinical Pathology.

In The Last Decade

Sheron C. Lear

16 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheron C. Lear United States 10 144 132 131 120 82 16 440
R Rondinone Italy 10 65 0.5× 57 0.4× 48 0.4× 111 0.9× 101 1.2× 19 366
Simon Rauber Germany 10 100 0.7× 231 1.8× 123 0.9× 41 0.3× 48 0.6× 20 510
Kaichi Kaneko Japan 14 98 0.7× 114 0.9× 160 1.2× 118 1.0× 30 0.4× 41 499
Yosuke Masamoto Japan 10 67 0.5× 144 1.1× 135 1.0× 99 0.8× 38 0.5× 57 444
Daniel Ching Australia 11 62 0.4× 91 0.7× 144 1.1× 46 0.4× 22 0.3× 28 429
Ning Kong China 11 96 0.7× 443 3.4× 155 1.2× 60 0.5× 48 0.6× 15 707
Yuri Masui Japan 14 71 0.5× 131 1.0× 110 0.8× 102 0.8× 230 2.8× 30 452
Hideaki Chazono Japan 13 130 0.9× 42 0.3× 161 1.2× 58 0.5× 35 0.4× 29 520
Ashraf Fakhrjou Iran 11 73 0.5× 49 0.4× 101 0.8× 53 0.4× 21 0.3× 37 345
Debomita Chakraborty Germany 4 51 0.4× 78 0.6× 121 0.9× 55 0.5× 109 1.3× 4 385

Countries citing papers authored by Sheron C. Lear

Since Specialization
Citations

This map shows the geographic impact of Sheron C. Lear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheron C. Lear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheron C. Lear more than expected).

Fields of papers citing papers by Sheron C. Lear

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheron C. Lear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheron C. Lear. The network helps show where Sheron C. Lear may publish in the future.

Co-authorship network of co-authors of Sheron C. Lear

This figure shows the co-authorship network connecting the top 25 collaborators of Sheron C. Lear. A scholar is included among the top collaborators of Sheron C. Lear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheron C. Lear. Sheron C. Lear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Slone, Stephen P., Alvin W. Martin, Samuel R. Wellhausen, et al.. (2008). IL‐4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils. Journal of Cutaneous Pathology. 35(s1). 38–45. 9 indexed citations
2.
Chesney, Jason, Mary Ann Rasku, Amy Clem, et al.. (2008). Transient T-cell depletion causes regression of melanoma metastases. Journal of Clinical Oncology. 26(15_suppl). 9030–9030. 2 indexed citations
3.
Rasku, Mary Ann, Amy Clem, Sucheta Telang, et al.. (2008). Transient T cell depletion causes regression of melanoma metastases. Journal of Translational Medicine. 6(1). 12–12. 118 indexed citations
4.
Janckila, Anthony J., Stephen P. Slone, Sheron C. Lear, Alvin W. Martin, & Lung T. Yam. (2007). Tartrate-Resistant Acid Phosphatase as an Immunohistochemical Marker for Inflammatory Macrophages. American Journal of Clinical Pathology. 127(4). 556–566. 48 indexed citations
5.
Janckila, Anthony J., Stephen P. Slone, Sheron C. Lear, Alvin F. Martín, & Lung T. Yam. (2007). Tartrate-Resistant Acid Phosphatase as an Immunohistochemical Marker for Inflammatory Macrophages. American Journal of Clinical Pathology. 127(4). 556–566. 3 indexed citations
6.
Malone, Janine C., et al.. (2006). CD10 Expression in Cutaneous Adnexal Neoplasms and a Potential Role for Differentiating Cutaneous Metastatic Renal Cell Carcinoma. Archives of Pathology & Laboratory Medicine. 130(9). 1315–1319. 27 indexed citations
7.
Aly, Hany, Mohamed Khashaba, Sheron C. Lear, et al.. (2005). Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic–ischemic central nervous system of human newborn infants. Neuroscience Letters. 378(1). 1–6. 23 indexed citations
8.
Moore, Grace D., et al.. (2005). Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method. Diagnostic Cytopathology. 32(2). 82–87. 13 indexed citations
9.
Malone, Janine C., Stephen P. Slone, Paul Fearneyhough, et al.. (2002). Vascular Inflammation (Vasculitis) in Sweet Syndrome. Archives of Dermatology. 138(3). 345–9. 93 indexed citations
10.
Lear, Sheron C., Anthony J. Janckila, Alvin W. Martin, & Lung T. Yam. (1997). Immunohistochemistry of Tartrate-Resistant Acid Phosphatase: Assessment of Steam Heat for Epitope Enhancement and Comparison of B-5 and Formalin Fixation. Journal of Histotechnology. 20(4). 303–306. 1 indexed citations
11.
Janckila, Anthony J., Hadi Yaziji, Sheron C. Lear, Alvin W. Martin, & Lung T. Yam. (1996). Localization of tartrate-resistant acid phosphatase in human placenta. The Histochemical Journal. 28(3). 195–200. 11 indexed citations
12.
Janckila, Anthony J., Sheron C. Lear, Alvin W. Martin, & L T Yam. (1996). Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase.. Journal of Histochemistry & Cytochemistry. 44(3). 235–244. 12 indexed citations
13.
Yaziji, Hadi, Anthony J. Janckila, Sheron C. Lear, Alvin W. Martin, & Lung T. Yam. (1995). Immunohistochemical Detection of Tartrate-Resistant Acid Phosphatase in Non-Hematopoietic Human Tissues. American Journal of Clinical Pathology. 104(4). 397–402. 73 indexed citations
14.
Janckila, Anthony J. & Sheron C. Lear. (1991). Let the Buyer Be Aware. Journal of Histotechnology. 14(2). 73–73. 1 indexed citations
15.
Case, J., et al.. (1988). Immunoperoxidase Technique on Paraffin Sections Fails to Demonstrate Immunoglobulin Deposition in Cutaneous Lesions from Patients with Dermatomyositis. American Journal of Dermatopathology. 10(4). 297–299. 4 indexed citations
16.
Schrodt, G. Randolph, et al.. (1987). Myoepithelial Cell Staining in Plastic Sections. Laboratory Medicine. 18(5). 313–315. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026